photo of

Details

Role Group Leader / Honorary Fellow Manager
Research area Infection, Immunity and Global Health
Group Molecular Microbiology
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.

Top Publications

  • Novakovic, Brotherton, J, Garland, S, Cheng, A, Booy, R, Walker, P, Berkowitz, R, Harrison, H, Black, R, Perry, C, et al. Lb1.7 Australian national surveillance of juvenile onset recurrent respiratory papillomatosis: declining incidence post quadrivalent hpv vaccination. Sexually Transmitted Infections 93(Suppl 2) : a43 2017
    view publication
  • de Sanjosé, S, Temin, S, Garland, S, Eckert, LO, Arrossi, S. Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline Summary. JCO Oncology Practice 13(7) : jop.2017.021949 2017
    view publication
  • Smith, KS, Guy, R, Danielewski, J, Tabrizi, SN, Fairley, CK, McNulty, AM, Rawlinson, W, Saville, M, Garland, SM, Donovan, B, et al. Biological and Behavioral Factors Associated With Positive Chlamydia Retests. Sexually Transmitted Diseases 44(7) : 417 -422 2017
    view publication
  • Tabrizi, SN, Su, J, Bradshaw, CS, Fairley, CK, Walker, S, Tan, LY, Mokany, E, Garland, SM. Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance. Journal of Clinical Microbiology 55(6) : 1915 -1919 2017
    view publication
  • Petersen, LK, Restrepo, J, Moreira, ED, Iversen, O-E, Pitisuttithum, P, Van Damme, P, Joura, EA, Olsson, S-E, Ferris, D, Block, S, et al. Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine – A combined analysis of five phase III clinical trials. Tumour Virus Research 3: 105 -115 2017
    view publication

Page 46 of 147

Related links